The Overnight Picture

U.S. equity markets enter Monday's session carrying the weight of Friday's selloff, triggered by a jobs report that came in stronger than markets had anticipated. Pre-market futures are absorbing that repricing, with the broader macro backdrop now firmly in control of near-term direction.

Asia and European markets have had the weekend to digest the data, but the core question remains unanswered: has the Federal Reserve's work on inflation genuinely stalled, or is the labor market simply proving more resilient than models expected? That distinction matters enormously for the rate path — and therefore for equity valuations across every sector.

AVGO was already a casualty before Friday's macro shock. Broadcom shares fell 12.59% after its second-quarter fiscal 2026 earnings disappointed, with Bank of America resetting its price target in the aftermath. The drop is a pointed reminder that AI-exposed semiconductor names are not insulated from earnings execution risk, particularly when valuations have been pricing in near-perfection.

Theme One: The Fed Is Back in the Room

The jobs report is the most watched economic release in the Fed's data-dependent framework, and Friday's print was unambiguous in its message: the labor market remains tight. That matters because persistent employment strength is typically associated with wage pressure, which feeds into services inflation — the component the Fed has found most stubborn.

Rate hikes work by increasing the cost of borrowing for businesses and consumers, slowing spending and investment. For equity markets, the transmission mechanism is more direct: higher rates raise the discount rate applied to future corporate earnings, mechanically compressing valuations. Growth stocks — technology names in particular — are disproportionately sensitive because their value is concentrated in earnings years away.

Friday's selloff was broad-based, not sector-specific. That breadth suggests the market read the jobs data as a systemic repricing event rather than a rotation. Oil diverged, holding onto weekly gains as commodity dynamics — supply constraints, demand signals — operated independently of monetary policy sentiment. That divergence is worth tracking: when energy holds while equities fall on rate fears, it often signals that inflation itself isn't going away quietly.

Any Fed commentary this week will be parsed with unusual intensity. Policymakers have been in data-dependent mode, and Friday's report hands hawks fresh ammunition.

Theme Two: Deal-Making Accelerates Despite the Macro Headwinds

The macro anxiety has not slowed corporate deal-making. Two transactions announced over the weekend represent the kind of strategic conviction that typically takes months to build.

In Europe, a Bouygues-led consortium signed a binding agreement to acquire SFR from Altice France for $23.4 billion — one of the largest telecom transactions in European M&A in recent years. Altice France has been under sustained pressure to reduce its debt load, and the SFR disposal represents a defining deleveraging move. For Bouygues, which already operates its own French mobile network, the combination would create a dominant force in a market that currently supports four major carriers.

Regulatory scrutiny is the primary execution risk. European competition authorities have historically viewed telecom consolidation with caution, concerned about reduced consumer choice and the pricing power that accrues to merged entities. No closing timeline was disclosed.

LLY moved in a different direction — outward expansion rather than consolidation. Eli Lilly committed nearly $4 billion across a cluster of acquisitions targeting vaccines and infectious disease, including deals for Curevo, LimmaTech Biologics, and Ascidian Therapeutics, alongside licensing arrangements with Hanmi Pharm and Haisco Pharmaceutical. The strategic logic is portfolio construction: Lilly's obesity and diabetes franchise has generated exceptional cash flows, and management is deploying that capital into earlier-stage, higher-risk therapeutic areas to reduce long-term revenue concentration risk as patents eventually expire.

Genetic medicine — which Ascidian Therapeutics represents — is an area where several large pharmaceutical companies are racing to establish early positions. Lilly's willingness to spread nearly $4 billion across multiple smaller targets suggests a portfolio approach rather than a single concentrated bet.

Theme Three: Meta's Capital Structure Question

META is reportedly weighing a large equity offering to fund its artificial intelligence infrastructure buildout. No terms or final decision have been confirmed, but the signal itself is significant.

Meta has historically been one of the most cash-generative companies in U.S. technology, funding its operations — including aggressive capital expenditure cycles — through advertising revenue rather than external financing. A decision to tap equity markets would indicate that the capital intensity of its current AI buildout has reached a scale that strains even Meta's formidable internal cash generation.

Equity dilution — the reduction in each existing shareholder's ownership percentage when new shares are issued — is the central concern for current investors. The trade-off is straightforward: near-term dilution in exchange for the infrastructure investment that management believes is necessary for long-term competitive positioning in AI. Whether that trade-off is acceptable depends heavily on what returns that infrastructure eventually generates.

The reported consideration also arrives in the context of Broadcom's earnings disappointment. If chipmakers and infrastructure suppliers are facing elevated execution risk, the economics of massive AI infrastructure spending deserve scrutiny — not just from Meta's shareholders, but from anyone holding AI-adjacent names.

The Calendar: What to Watch Today

No major U.S. economic releases are scheduled for Monday, June 8. The session's direction will be shaped primarily by how markets continue to process Friday's jobs data and whether any Fed officials speak publicly.

Watch for any commentary from Federal Reserve policymakers — even informal remarks can move rate expectations when the market is in an active repricing mode. The jobs report has reset the probability distribution around the Fed's next move, and any official guidance will be treated as directional.

On the corporate side, further details on Meta's potential equity offering are the most market-sensitive pending story. Any confirmation of size, structure, or timeline would move the stock and potentially ripple through broader tech sentiment. For Broadcom, watch whether Friday's 12.59% decline attracts institutional buying at lower levels or whether the earnings miss prompts further downward revisions from the analyst community beyond Bank of America's initial reset.

The Bouygues-SFR deal will begin its regulatory journey, though meaningful competition authority decisions operate on a timeline of months. European telecom stocks may react to the deal's implications for sector consolidation more broadly.

Watch List

Fed speakers: Any public remarks from Federal Reserve officials carry outsized weight this week. The jobs data has reopened the rate debate, and markets need clarity on whether policymakers view Friday's print as a one-off or a trend.

META: Confirmation or denial of the equity offering would be a binary catalyst. Monitor for any SEC filings, banker mandates, or executive commentary.

AVGO: After a 12.59% single-session decline, the stock enters Monday at a reset valuation. Watch whether buy-side interest emerges or whether guidance revisions continue.

LLY: The $4 billion acquisition spree diversifies the pipeline but introduces integration and clinical execution risk across multiple early-stage targets. Any analyst commentary on deal economics will shape near-term sentiment.

Oil: Energy's divergence from equities on Friday was notable. If crude continues to hold gains while rate fears weigh on stocks, it complicates the Fed's task and reinforces the case for a higher-for-longer rate environment.